Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tomas Guldsmed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 3.6% 3.6%   Bankruptcy risk   8.6% 8.1% 7.5% 7.4% 7.4% 7.0% 18.0% 18.0%   Credit score (0-100)   30 31 32 31 32 33 8 8   Credit rating   BB BB BB BB BB BBB B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   714 839 699 735 0 0 0 0   Gross profit   489 640 490 513 336 510 0.0 0.0   EBITDA   7.7 154 10.2 -88.7 -160 -0.0 0.0 0.0   EBIT   7.7 154 10.2 -88.7 -160 -0.0 0.0 0.0   Pre-tax profit (PTP)   -90.6 0.0 10.7 8.7 -164.6 -14.4 0.0 0.0   Net earnings   -92.0 0.0 10.7 8.7 -164.6 -14.4 0.0 0.0   Pre-tax profit without non-rec. items   -90.6 0.0 10.7 8.7 -165 -14.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   649 649 649 649 649 649 0.0 0.0   Shareholders equity total   -817 -817 -806 -797 -961 -1,157 -1,207 -1,207   Interest-bearing liabilities   1,706 1,810 1,845 1,896 2,088 1,939 1,207 1,207   Balance sheet total (assets)   1,133 1,251 1,306 1,495 1,370 1,326 0.0 0.0   Net Debt   1,566 1,650 1,707 1,751 1,968 1,790 1,207 1,207     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   714 839 699 735 0 0 0 0   Net sales growth   -21.9% 17.4% -16.7% 5.2% -100.0% 0.0% 0.0% 0.0%   Gross profit   489 640 490 513 336 510 0.0 0.0   Gross profit growth   41.1% 30.8% -23.5% 4.8% -34.5% 51.6% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,133 1,251 1,306 1,495 1,370 1,326 0 0   Balance sheet change%   -3.3% 10.5% 4.4% 14.5% -8.4% -3.2% -100.0% 0.0%   Added value   7.7 154.1 10.2 -88.7 -160.5 -0.0 0.0 0.0   Added value %   1.1% 18.4% 1.5% -12.1% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 -649 0   Net sales trend   -2.0 1.0 -1.0 1.0 -1.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   1.1% 18.4% 1.5% -12.1% 0.0% 0.0% 0.0% 0.0%   EBIT %   1.1% 18.4% 1.5% -12.1% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.6% 24.1% 2.1% -17.3% -47.7% -0.0% 0.0% 0.0%   Net Earnings %   -12.9% 0.0% 1.5% 1.2% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -12.9% 0.0% 1.5% 1.2% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -12.7% 0.0% 1.5% 1.2% 0.0% 0.0% 0.0% 0.0%   ROA %   0.4% 7.7% 6.6% 0.6% -6.9% 0.0% 0.0% 0.0%   ROI %   0.5% 8.8% 7.5% 0.7% -8.1% 0.0% 0.0% 0.0%   ROE %   -8.0% 0.0% 0.8% 0.6% -11.5% -1.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -41.9% -39.5% -38.2% -34.8% -41.2% -46.6% -100.0% -100.0%   Relative indebtedness %   273.0% 246.6% 302.4% 312.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   253.3% 227.6% 282.7% 292.4% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   20,306.4% 1,071.2% 16,722.4% -1,974.7% -1,226.2% -29,832,066.7% 0.0% 0.0%   Gearing %   -208.8% -221.5% -228.8% -237.9% -217.1% -167.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.9% 8.8% 6.9% 0.2% 0.2% 0.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.2 0.3 0.3 0.4 0.3 0.3 0.0 0.0   Cash and cash equivalent   140.0 159.3 137.5 144.3 119.7 148.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   11.0 5.3 6.3 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   234.0 290.3 214.7 300.6 0.0 0.0 0.0 0.0   Current assets / Net sales %   67.7% 71.8% 94.1% 115.2% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,465.5 -1,465.5 -1,454.9 -1,445.4 -1,610.0 -1,805.5 -603.4 -603.4   Net working capital %   -205.2% -174.7% -208.3% -196.8% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0